
Peter Mantas Returns
The Business Brew
00:00
Where MaxCyte and Maravai Fit In
Bill asks about MaxCyte and Maravai; Peter discusses cost issues, capacity, M&A potential, and timelines for recovery.
Play episode from 01:17:55
Transcript

Bill asks about MaxCyte and Maravai; Peter discusses cost issues, capacity, M&A potential, and timelines for recovery.